Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.
This New Jersey bill (A 1636) classifies 7-Hydroxymitragynine as a Schedule I controlled substance and bans the sale, manufacture, and distribution of any product containing it. The law requires manufacturers and distributors to immediately recall any products containing the substance, mandates retailers to remove such products from shelves within 48 hours, and requires retailers to return recalled inventory to manufacturers within 30 business days. Violations are punishable as crimes, ranging from fourth-degree offenses for first violations to second-degree crimes for repeat offenses. The bill directly affects businesses selling or handling products with 7-Hydroxymitragynine, including manufacturers, distributors, and retailers.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026
Last action Jan 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Consumer Affairs Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Sean Kean
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about A 1636
Scope: NJ
Hi! I can help you understand A 1636. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline